Translational Medicine: Open Access(TMOA)

Translational Medicine: Open Access is an online peer-reviewed open-access journal that focuses on information derived from human experimentation so as to optimize the communication between basic and clinical science aiming to provide practical, up-to-date information on the significant research from all subspecialties of medicine and broaden the readers' vision and horizon from bench to bedside and bedside to bench. The journal aims to publish high-quality original research, early-stage innovation reports, innovative studies, and systemic and narrative reviews.

The journal is published online as a continuous volume and issue throughout the year. Articles are made available as soon as they are ready to ensure that there are no unnecessary delays in getting content publicly available. Translational Medicine: Open Access is an online high-impact open-access journal that aims to promote and accelerate the translation of preclinical research to a clinical application.

Special collections of articles are welcomed and will be published as part of the normal issue, but also within a separate collection page.

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Authors of articles published remain the copyright holders and grant third parties the right to use, reproduce, and share the article according to the Creative Commons license agreement.

The journal also aims to ensure innovators, clinicians, doctors, researchers, and scientists stay informed on and accelerate the adoption of the latest innovations that will make the biggest impact on healthcare.

Translational Medicine: Open Access publishes research articles, reviews, commentaries, clinical images, short communications, letters to the editor, case reports, and conference proceedings in the emerging field of clinical, medical, and healthcare. The journal covers: translational signaling and system biology, translational ophthalmology, translational metagenomics, translational medicines ‘ecosystem’, translational imaging, translational hematology, translational genomics and genetics, translational craniofacial and dental medicine, translational cancer biology, personalized medicine, patient-targeted molecular therapies, pain, critical care and anesthesia, medical bioinformatics, immune radiobiology, emerging therapeutics, clinical translation, cell, tissue and gene therapy, cancer metabolism and other related studies.